Since 2009, we have supported more than 2000 medical device registrations, and the first question that almost always comes up from foreign manufacturers is: \"Why does this process feel more complex than back home?\"<\/p>\n\n\n\n
The answer comes down to one principle that gets overlooked: in Indonesia, the Izin Edar (market authorization) is tied to the license holder, not just the product. International manufacturers without a legal entity in Indonesia are required to appoint a Local Authorized Representative (LAR), who carries regulatory responsibility on their behalf.<\/p>\n\n\n\n
This guide walks through the full medical device registration process in Indonesia for 2026, from product classification to post-market obligations, based on the Permenkes 11\/2025 framework now in full effect.<\/p>\n\n\n\n
Every medical device in Indonesia is classified by risk level:<\/p>\n\n\n\n
This classification determines which technical documents are required, the evaluation pathway, and the estimated timeline. The most common mistake we see: manufacturers assume Indonesia's risk classes map directly onto their home country's classes, when the criteria are not always identical.<\/p>\n\n\n\n
There are two main routes:<\/p>\n\n\n\n
We usually advise clients to choose based on the scale of their long-term business plan, not just short-term speed.<\/p>\n\n\n\n
The technical dossier for registration includes clinical evidence, safety testing results, product standards compliance, and labeling adapted to Indonesian requirements. Documentation from your home country (CE, FDA, NMPA) can serve as a base, but still needs to be reformatted, translated, and evaluated by the Ministry of Health.<\/p>\n\n\n\n
Any entity distributing medical devices in Indonesia, including a LAR, must hold CDAKB certification (Indonesia's good distribution practice standard, roughly equivalent to GDP). This is separate from the Izin Edar, but the two need to stay aligned.<\/p>\n\n\n\n
Registration timelines typically range from 1 to 3 months, depending on risk class and documentation completeness. The process runs through the Ministry of Health's online system, and regular communication with the evaluator often determines how quickly follow-up questions get resolved.<\/p>\n\n\n\n
Once the Izin Edar is issued, the obligations do not stop. Post-market surveillance, adverse event reporting, and annual CDAKB audits continue for as long as the product is on the Indonesian market. Many companies treat registration as the finish line, when it is really the start of an ongoing compliance obligation.<\/p>\n\n\n\n
Medical device registration in Indonesia is not a single step, but a chain of connected decisions, from product classification through to long-term compliance. Manufacturers who build their regulatory strategy early, rather than after a launch date is already set, consistently reach the market faster.<\/p>\n\n\n\n
PT. Deray Global Utama is an Indonesia-based regulatory consultancy with over 15 years of experience supporting medical device registration. Reach us at info@derayglobalutama.com for an initial consultation.<\/p>\n\n\n\n